After a tumultuous year of proposed program cuts and eliminations, Congress has agreed to reject them and instead has maintained funding for domestic HIV prevention and treatment programs on a bipartisan basis. Now, the Trump administration must focus its attention on properly implementing these programs in order to get the nation back on track to end HIV in the U.S.
House Republicans Go Way Beyond President’s Budget by Ending all HIV Prevention & Slash AIDS Care by 20%
This is not a bill for making America healthy again, but a disastrous bill that will reignite HIV in the United States. We urge Congress to reject these reckless cuts. Eliminating all HIV prevention means the end of state and local testing and surveillance programs, educational programs, and linkage to lifesaving care and treatment, along with PrEP. It will translate into an increased number of new HIV infections, which will be costlier to treat in the long run. At a time when we have the tools to prevent HIV, including new long-acting forms of PrEP, we must not abandon the bipartisan progress our nation has made in combatting HIV.
Senate Appropriators Reject Trump HIV Prevention Budget Cuts, While Maintaining Care, Treatment, and PrEP
Today, on a bipartisan basis, the Senate Appropriations Committee rejected the Trump administration’s proposed elimination of CDC’s HIV prevention and surveillance programs. On a vote of 26 to 3, the Committee approved the Fiscal Year 2026 Labor, HHS Appropriations bill that maintains funding for existing domestic HIV prevention along with the care, treatment, and PrEP programs that were included in the president’s budget.
FDA Approves Twice-Yearly HIV Prevention Drug
Today marks a monumental advance in HIV prevention. Congratulations to the many researchers who spent nineteen years to get to today’s approval, backed up by the long-term investment needed to get the drug to market. Long-acting PrEP is now not only effective for up to six months but also improves adherence and will reduce HIV infections—if people are aware of it and payers, including private insurers, cover it without cost-sharing as a preventive service.
Massive Budget Cuts Proposed in “Skinny Budget”
In response to the release of the “skinny budget” released by the White House today, Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, issued the following statement: “While there are still many unknowns, what we do know is the budget the Trump administration proposed today contains massive cuts that will damage the future health of our country. On the positive side, it appears that most existing HIV care and treatment programs, including most components of the Ryan White HIV/AIDS Program and its part of the Ending the HIV Epidemic (EHE) initiative, would remain intact. If true, this marks a reversal from the leaked draft budget which eliminated the EHE initiative. However, the budget completely ignores HIV prevention at CDC, which includes surveillance, testing, PrEP programs, and linkage to care. It is not known if it is zeroed out, cut, or moved to another part of HHS, as has previously been reported. The Ending the HIV Epidemic initiative is also not on the list of programs being eliminated, but since it is not a detailed budget this is not fully known. The cuts to the Ryan White HIV/AIDS Program would impact critical services such as dental reimbursements, training, and community-driven implementation research.”